Orchid Chem receives EU approval for bacterial injection

News Flash

JUSTICE RAVEENDRAN'S ACTIONS A SURPRISE; TO CAUSE DELAYS IN CASE
JUSTICE RAVEENDRAN RECUSES HIMSELF FROM RIL- RNRL CASE
PFRDA BILL LIKELY TO COME UP IN THE WINTER SESSION OF PARLIAMENT
SBI AMENDMENT BILL & SBI SUBSIDIARIES BILL TO BE CLEARED IN WINTER SESSION
PENSION BILL LIKELY TO BE TABLED IN THE WINTER SESSION OF PARLIAMENT
FIN MIN WANTS BANKING REGULATION ACT EXEMPTED FROM COMPETITION COMMISSION
INFLATION SEEN ABOVE 4-5% COMFORT ZONE BY MARCH END
FY11 GDP GROWTH SEEN AT 8% ON NORMAL MONSOON & GLOBAL RECOVERY
FY'10 GDP GROWTH SEEN AT 5.5% IN WORST CASE SCENARIO
INDIA'S GDP GROWTH IN FY'10 MAY BE 6.3% ON WEAK MONSOON
TO INCREASE CORUS CAPACITY USE TO 100% BY MARCH NEXT YEAR
CORUS UNIT RAN AT 80% CAPACITY IN OCTOBER
CUTS RATING ON SEMICONDUCTOR STOCKS TO 'CAUTIOUS' VS 'ATTRACTIVE'
TURNAROUND IN GLOBAL ECONOMY MAY SIGNAL REVIVAL FOR TANKER MARKET
SHIPPING MARKET TO POST A TURNAROUND SOMETIME IN 2011
OCT FLAT PRODUCT OUTPUT AT 296,000 TONS VS 248,000 TONS (YOY)
OCT CRUDE STEEL OUTPUT AT 453,000 TONS VS 338,000 TONS (YOY)
TO RAISE METAL PRICES BY RS.1000/TN
CUT FLAT PRODUCT PRICES BY RS.750-1500/TONNE THIS MONTH
PRICES TO STABILISE AT CURRENT LEVELS; SAIL OCT SALES UP 30% (YOY)
HAVE SHIFTED FOCUS FROM DEFENSIVES TO RATE SENSITIVE SECTORS
SEE NIFTY TOUCHING 5200 LEVELS IN SHORT TERM
TURNAROUND IN GLOBAL ECONOMY MAY SIGNAL A REVIVAL FOR TANKER MARKET
NEW SC PANEL TO BE CONSTITUTED, HEARING TO START FROM NOV 5
JUSTICE RAVEENDRAN RECUSES HIMSELF FROM RIL RNRL CASE
UTTAR PRADESH TEMPORARILY BANS IMPORTS OF RAW SUGAR : AGENCIES
UTTAR PRADESH TEMPORARILY BANS IMPORTS OF RAW SUGAR : AGENCIES
SENSEX MAY SLIP TO 13000 LEVELS IN NEAR TERM; SEE MORE DOWNSIDE ON MARKETS
REAL ESTATE AND TELECOM STOCKS LIKELY TO BREAK THEIR MARCH LOWS
RIL TRADING AT 15-18X PE LOOKS COSTLY; SEE SCOPE FOR MORE CORRECTION

Updated: 04/08/2008 | 06:34 PM IST

Top Stories

Press Trust of India

Monday, August 04, 2008 (Mumbai)

Blog

Comments:

Read (0)

Post

Rate the story

Orchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazobactam injection, used in the treatment of bacterial infection.

The Chennai-based generic pharma firm filed the marketing authorisation for this product with the UK Medicines and Healthcare products Regulatory Agency to enable the company to launch the product across EU countries, Orchid Chemicals said in a filing to Bombay Stock Exchange.

Piperacillin and Tazobactam for injection is used in the treatment or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

"Through this approval, we are expanding into a new product range of premium Penicillin Injectables and also foraying into EU generic market," Orchid Chemicals and Pharmaceuticals Managing Director K Raghavendra Rao said.

The company is launching the injection in the European Union through its exclusive marketing alliance with Hospira, Rao added.

Shares of the company closed at Rs 259.60, up 3.67 per cent on the BSE on Monday.